Trelegy ellipta and Dehydration - a phase IV clinical study of FDA data

Summary:

Dehydration is reported as a side effect among people who take Trelegy ellipta (fluticasone furoate; umeclidinium bromide; vilanterol trifenatate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Fluoxetine, and have Chronic obstructive pulmonary disease.

The phase IV clinical study analyzes which people have Dehydration when taking Trelegy ellipta. It is created by eHealthMe based on reports of 27,966 people who have side effects when taking Trelegy ellipta from the FDA, and is updated regularly.

What is Trelegy ellipta?

Trelegy ellipta has active ingredients of fluticasone furoate; umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 28,101 Trelegy ellipta users. Check the latest studies of Trelegy ellipta.

What is Dehydration?

Dehydration (dryness resulting from the removal of water) is found to be associated with 2,755 drugs and 3,349 conditions by eHealthMe. Check the latest studies of Dehydration.

On Jul, 13, 2026

27,966 people reported to have side effects when taking Trelegy ellipta.
Among them, 88 people (0.31%) have Dehydration.

Could Trelegy ellipta cause Dehydration?

Among these 88 people:

How long have people been on Trelegy ellipta when they have Dehydration? *

What is the gender of people who have Dehydration when taking Trelegy ellipta? *

female: 66.23 %
male: 33.77 %

What is the age of people who have Dehydration when taking Trelegy ellipta? *

What are other drugs people take besides Trelegy ellipta? *

What are other side effects people have besides Dehydration? *

Nausea (feeling of having an urge to vomit): 19 people, 21.59%
Diarrhea: 18 people, 20.45%
Dyspnea (difficult or laboured breathing): 16 people, 18.18%
Hypophagia (reduced food intake): 14 people, 15.91%
Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 14 people, 15.91%
Fatigue (feeling of tiredness): 14 people, 15.91%
Weakness: 13 people, 14.77%
Cough: 13 people, 14.77%
Urinary Tract Infection: 12 people, 13.64%
Stress And Anxiety: 11 people, 12.50%

What are the existing conditions these people have? *

Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 12 people, 13.64%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 8 people, 9.09%
Asthma: 8 people, 9.09%
Constipation: 4 people, 4.55%
Neuropathy Peripheral (surface nerve damage): 4 people, 4.55%
Nausea (feeling of having an urge to vomit): 4 people, 4.55%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 4.55%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 4.55%
Depression: 3 people, 3.41%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 3.41%

* Approximation only. Some reports may have incomplete information.

Do you take Trelegy ellipta and have Dehydration?

- Check whether Dehydration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trelegy ellipta:

Trelegy ellipta (28,101 reports)

Dehydration treatments and more:

Dehydration (173,274 reports)

How severe was Dehydration and when was it recovered:

Dehydration in Trelegy ellipta

Expand to all the drugs that have ingredients of fluticasone furoate; umeclidinium bromide; vilanterol trifenatate:

Dehydration and drugs with ingredients of fluticasone furoate; umeclidinium bromide; vilanterol trifenatate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trelegy ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dehydration:

Dehydration (2,755 drugs)

Browse all the conditions that are associated with Dehydration:

Dehydration (3,349 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone furoate; umeclidinium bromide; vilanterol trifenatate (the active ingredients of Trelegy ellipta) and Trelegy ellipta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.